2026-01-20 LIDR Meeting Notes

Hung Luu

Children’s

Riki Merrick

Vernetzt, APHL

Andrea Pitkus

University of Wisconsin

Pam Banning

3M - Solventum

Xavier Gansel

Biomerieux

Amy McCormick

Epic

Dan Rutz

Epic

Rob Rae

CAP

Rob Hausam

Hausam Consulting

Stan Huff - regrets

University of Utah

Ed Heierman

Abbott / IICC

Carmen Pugh

long term lab professional

Laurent Lardin

Biomerieux

Ralf Herzog

Roche

Christina Gallegos

APHL

Follow up on UDI representation

Adding Conclusion here:

Will keep filling this page out to collect all solutions there.

USCDI elements

CDC submitted new datalements for USCDI - ASTP is looking for use cases to support adding those elements (why do providers need this for decision making?):

• specimen received date (= in process status of the order)

  • this correlates to notification that specimen is in lab (for example a repeating test on a patient, an urgent test can now be worked on, sample already drawn and in lab, so could avoid re-order, or get add-on test)

  • affects the evaluation of specimen acceptabilty - but this would then be reflected in specimen condition (see chat) - also important for medicolegal chronology

  • is a CLIA required element (most important for the lab)

  • any element that must be included in the report, the EHR-s has to support this element

• lab test performed date

  • is this affected by prior auth evaluation (or is this the collection date)?

  • re-analyzing of samples (genetics)

  • supporting internal QA

• result report status change date/time (P to F, F to C) - this is essentially the same as report date (because it is a new report)

  • this can affect patient treatment (micro or pathology), as changes in results should be re-evaluated

  • this is for the date, not the status change, so helps to pull together the treatment/diagnostics timeline, identifying what result is the newest

  • this also has medicolegal implications (result chronology)

Specimen collection date/ time has been accepted finally!

Where should we do this work - ask on the ALL SHIELD call later today!

LIDR Patterns

• Biomerieux culture plates

• Toxicology screening vs confirmatory

• challenge tests

• urine dipstick variations

• required specimen pre-processing before running on instrument?

Action Item Follow up

• State of LIDR tooling: Some of the Biomerieux content is in KOMET which is now referred to as the device extension (DeX) = LIDR (is in GitHub here: https://github.com/ikmdev/komet) - there will be another IKE community meeting

  • Date: Thursday, January 29th
    Time: 2:00-4:00 PM EST
    Location: Virtual
    Register here for the meeting link

• Pull out the definitions from LIVD for test kit and equipment and put here: SHIELD Glossary

  • Review operational definition of “equivalence”

    • Will look for a CLSI defintion

    • also check IFCC definition

• Outreach to Dr. DeBaca

  • Hung will check for more info and maybe see, if she could participate in SHIELD

• Keep updating the googlesheet: Potassium LIVD data

• Shared Reportable Conditions LIVD google sheet for crowdsourcing with CSTE - added sign up sheet for PHAs to specific conditions and see how that develops

• Have LIVD File Repository Requirements

  Have draft budget (for setting up a web-based database and yearly maintenance): https://aphlinformatics.atlassian.net/wiki/download/attachments/915407143/LIDR - Budget.xlsx?api=v2

• Define next steps to migrate existing LIVD files into FHIR LIVD catalog format and find a FHIR server to host

Next call

Tuesday ​Feb 3, 2026 9 - 10 AM ET